The short version of GLP-1 analog fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-07-29 and is reviewed periodically as new material appears.
Activation of the GLP-1 receptor couples to Gs signalling and raises intracellular cyclic AMP in pancreatic beta cells. The resulting insulin release depends on prevailing glucose concentrations, so the effect is greater when glucose is elevated. Receptor engagement also suppresses glucagon secretion and slows gastric emptying, which flattens post-meal glucose excursions. In the central nervous system, signalling in hypothalamic and brainstem regions is associated with reduced appetite and lower energy intake. Studies continue to examine effects on cardiac, renal and hepatic endpoints; whether those benefits are independent of weight change remains an open question.
Clinical development of this compound followed earlier short-acting GLP-1 analogues that required frequent injection. Once-weekly subcutaneous formulations entered use after 2017, and an oral formulation using a permeation enhancer later became available. The oral version pairs the peptide with sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, a carrier that improves uptake across the gastric epithelium. Interest has expanded from glycaemic control into weight management and metabolic liver disease. Regulatory status and approved indications differ between countries, and the product remains subject to ongoing safety monitoring.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.
GLP-1 receptors are expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises cyclic AMP, enhances glucose-dependent insulin secretion, and suppresses glucagon release when blood glucose is high. Effects on gastric emptying and on hypothalamic appetite circuits reduce energy intake. Because insulin release remains glucose-dependent, the risk of hypoglycemia is low when the drug is used alone. The precise contribution of each pathway to body weight change in humans remains an area of active investigation.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C187H291N45O59 | Parent peptide; salt forms also reported |
| Molecular mass | about 4113.6 Da | Average mass of the free peptide |
| Peptide length | 31 amino acids | Backbone related to GLP-1(7-37) |
| Key substitution | Aib at position 8 | Blocks DPP-4 cleavage |
| Albumin binding | Via C-18 diacid side chain | Prolongs circulation time |
Identity and purity are usually assessed by reverse-phase high-performance liquid chromatography coupled to mass spectrometry. Retention time and observed mass are compared against a reference standard run under identical conditions. Impurity profiles reveal deamidation products, oxidized methionine variants, and truncated fragments that arise during synthesis or storage. Peptide mapping through enzymatic digestion confirms the primary sequence, while amino acid analysis offers an independent check on overall composition.
Stability studies examine how temperature, pH, and moisture influence degradation rates over time. In aqueous solution, hydrolysis and deamidation accelerate as pH moves away from mildly acidic conditions. Light exposure and residual metal ions can also trigger oxidation of susceptible residues. Accelerated aging at elevated temperature is used to estimate shelf life, though extrapolation to room temperature carries uncertainty because individual degradation pathways do not always scale predictably.
Lyophilized semaglutide powder is typically held at minus twenty degrees Celsius for long-term storage. At that temperature, solid-state degradation reactions proceed slowly and the peptide remains intact for extended periods. Repeated freeze-thaw cycles are best avoided because they promote aggregation and can shift the proportion of monomeric peptide present. Working aliquots are often prepared so that each portion is thawed only once, and desiccant is placed inside the vial to limit moisture uptake.
Reconstituted solutions are less stable than the dry powder, and stability depends on concentration, pH, buffer composition, and container material. Low-protein-binding tubes reduce loss of peptide to plastic surfaces. Some researchers add a carrier protein to limit adsorption at low concentrations. The exact shelf life of a given solution is best determined empirically through a stability study rather than assumed from general guidance, because published data cover only a limited set of conditions.
Storage conditions for semaglutide depend heavily on the presentation. Lyophilized research powder is generally kept at two to eight degrees Celsius in a sealed container, protected from light and moisture. Manufacturer labeling for finished injectable products specifies refrigeration before first use, with defined in-use periods at room temperature afterward. The oral tablet form is stored at controlled room temperature and is more tolerant of short excursions. Temperature excursions should be documented rather than inferred.
Peptide degradation follows several routes. Hydrolysis cleaves the backbone at susceptible residues, oxidation targets methionine and tryptophan side chains, and aggregation produces higher-molecular-weight species that are difficult to reverse. Light exposure accelerates oxidation, which is why amber glass or opaque secondary packaging is common. Repeated freeze-thaw cycles promote aggregation and are best avoided. Stability-indicating methods detect these changes before they become visible.
The primary target is the GLP-1 receptor, a class B G protein-coupled receptor expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises intracellular cyclic AMP, which potentiates glucose-dependent insulin secretion and lowers glucagon release when blood glucose is elevated. Signalling in the hypothalamus and brainstem is associated with reduced appetite and slower gastric emptying. Because the insulinotropic effect depends on prevailing glucose levels, the hypoglycaemic risk of the peptide alone is described as low in most study settings. The relative contribution of peripheral and central actions remains an active research question.
Large randomised trials in adults with type 2 diabetes and in adults with obesity have reported reductions in body weight and improvements in several cardiovascular risk markers. One outcome trial found a lower incidence of major adverse cardiovascular events in participants with diabetes and established cardiovascular disease. Gastrointestinal effects such as nausea and vomiting are the most frequently reported adverse events and often diminish over time. Changes in lean body mass during weight loss are an area of ongoing investigation. Effects in adolescents and in pregnancy are less well characterised, and current labelling advises against use during pregnancy.
== History == Normal pentane was discovered in 1862 by Carl Schorlemmer, who, while analyzing pyrolysis products of the cannel coal mined in Wigan, identified, separated by fractional distillation and studied a series of liquid hydrocarbons inert to nitric and sulfuric acids. The lightest of them, which he called hydride of amyl, had an empirical formula of C5H12, density of 0.636 at 17 °C and boiled between 39 and 40 °C. In the next year he identified the same compound in the Pennsylvanian oil. By 1872 he switched his nomenclature to the modern one, leading to it being called Pentane. Beyond Schorlemmer's initial work, scientists discovered that the molecular formula C5H12 could represent different structural arrangements, leading to the identification of isopentane and neopentane. This discovery contributed significantly to the understanding of isomerism and hydrocarbons in the 19th century. The high volatility and low boiling point of pentane made it useful as a solvent and in fuels. Its use expanded in the 1970s as a blowing agent for foams, replacing CFCs. The petroleum refining industry utilizes pentanes, particularly isopentane, to produce high-octane fuels.
== Major political parties in parliament == African National Congress The ANC was founded in 1912, but were banned by State President Charles Robberts Swart in 1960, remaining so until the ban was lifted thirty years later by President F. W. De Klerk. The ANC became the leading political party in South Africa after the first multi-racial election in 1994. The party's main platform, which is based on a social democratic ideology, rests on working towards racial equality and eradicating the socio-economic classes which are often based on race. The ANC has been considered a party for native South Africans, especially before 2009 when party leader Jacob Zuma faced multiple accusations regarding corruption, particularly using public funds for his own purposes. The economic difficulties in South Africa, as well as police brutality have both been blamed on the ANC. Currently, the ANC holds 230 seats in parliament. Support for the ANC went down between the 2014 and the 2019 general elections, with violent protests erupting all over the country in response to the allegations of corruption within the ANC and the non-delivery of municipal services. Democratic Alliance The DA was formed when the New National Party, the successor to the apartheid-era National Party, merged with the Democratic Party and the Federal Alliance in 2000 to form an alliance. The DA is an opposition party and has been traditionally supported by South Africa's minority communities (White, Coloured and Indian).
==== Biomarkers of exposure ==== Several tests can determine exposure to benzene. Benzene itself can be measured in breath, blood, or urine, however such testing is usually limited to the first 24 hours post-exposure due to the relatively rapid removal of the chemical by exhalation or biotransformation. The majority of people in developed countries have measureable baseline levels of benzene and other aromatic petroleum hydrocarbons in their blood. In the body, benzene is enzymatically converted to a series of oxidation products including muconic acid, phenylmercapturic acid, phenol, catechol, hydroquinone and 1,2,4-trihydroxybenzene. Most of these metabolites have some value as biomarkers of human exposure, since they accumulate in the urine in proportion to the extent and duration of exposure, and they may still be present for some days after exposure has ceased. The current ACGIH biological exposure limits for occupational exposure are 500 μg/g creatinine for muconic acid and 25 μg/g creatinine for phenylmercapturic acid in an end-of-shift urine specimen.
Sources: en.wikipedia.org
The Soviet Union, officially the Union of Soviet Socialist Republics (USSR), was a transcontinental country that spanned much of Eurasia from its formation in 1922 until its dissolution in 1991. It was the world's third-most populous country, the largest by area, and bordered twelve other countries. A diverse multinational state, it was organized as a federal union of national republics, with the largest and most populous being the Russian Soviet Federative Socialist Republic (SFSR). The world's flagship communist state, it was governed by the Communist Party under Marxism–Leninism, through soviet councils. The Soviet economy was also centrally planned. Its capital and largest city was Moscow. The Soviet Union's roots lay in the October Revolution of 1917. The new government, led by Vladimir Lenin, established the Russian SFSR, the world's first constitutionally communist state. Following the Bolshevik victory in the Russian Civil War, the Russian SFSR and its subordinate republics were merged into the Soviet Union in 1922. Following Lenin's death in 1924, a six-year power struggle saw Joseph Stalin emerge as the country's undisputed personalist ruler. He initiated rapid industrialization and forced collectivization that led to significant growth, but contributed to a devastating famine in the 1930s that killed millions. The Soviet forced labour camp system, known as the Gulag, was expanded. During the late 1930s, Stalin's government conducted the Great Purge to eliminate opposition, resulting in deportations, executions, and the Moscow trials.
== Early life and education == Harriet Jane Lawrence was born on September 13, 1883, in Kingsbury, Maine. She began working as a teacher at the age of fifteen and used her earnings to help finance her continued education. Through savings from her teaching work, she was able to pursue higher education and eventually enroll in medical school. Lawrence attended Boston University School of Medicine, where she earned her medical degree in 1912. She was one of six women in her graduating class at a time when women remained significantly underrepresented in medical education. She later received the 1963 Distinguished Alumni Award from Boston University in acknowledgment of her contributions to medicine and work to advance women in the field.
== Doubly substituted isotopologues == Measurement of the abundance of clumped isotopes (doubly substituted isotopologues) of gases has been used in the field of stable isotope geochemistry to trace equilibrium and kinetic processes in the environment inaccessible by analysis of singly substituted isotopologues alone. Currently measured doubly substituted isotopologues include:
== Further reading == Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, et al. (May 2020). "Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction". N Engl J Med. 382 (20): 1883–1893. doi:10.1056/NEJMoa1915928. hdl:11370/94a25118-d24e-4efa-94a0-3b46279b519c. PMID 32222134.
Sources: en.wikipedia.org
It belongs to the incretin mimetic class and acts as a long-acting glucagon-like peptide-1 receptor agonist. The class includes several peptides with different half-lives and routes of administration.
The side chain enables reversible binding to albumin in the bloodstream, which protects the peptide from rapid renal clearance. This extends the interval between administrations compared with unmodified GLP-1.
No. It shares much of the native sequence but carries substitutions and an added side chain. These changes increase stability against enzymatic breakdown.
It is given either as a once-weekly subcutaneous injection or as an oral tablet taken once daily. The two forms use different absorption strategies, so they are not interchangeable on a milligram-for-milligram basis.